Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies

RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies

US Patent 6468983 · Granted Oct 22, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Zavarzinia compransoris capable of degrading organophosphorus flame retardant an2025
Cerium dioxide-supported low-dose PtCu ultrafine alloy catalyst, preparation met2025
Convenient and small near-ground atmospheric-boundary-layer wind tunnel and its 2024
Three-dimensionally ordered macroporous oxygen-deficient cerium dioxide catalyst2024
Disruption of the WAVE3 protein complex for suppression of invasion and metastas2023
Nitrogen-doped mesoporous carbon-coated titanium dioxide composite photocatalyst2023
Method, system, server, and storage medium for logistics management based on QR 2023
Pseudomonas aeruginosa with monomethylamine degradability and application thereo2023
Lysinibacillus fusiformis with methylamine degradability and application thereof2021
High precision decade capacitance standard box2021
Disruption of the WAVE3 protein complex for suppression of invasion and metastas2020
Short channel ordered mesoporous carbon loaded indium cobalt sulfide and indium 2020